ProNAi Reports 2015 Year-End Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
ProNAi Therapeutics (DNAI) Tops Q4 EPS by 20c
March 3, 2016 7:10 AM ESTProNAi Therapeutics (NASDAQ: DNAI) reported Q4 EPS of ($0.38), $0.20 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
... More